Sophiris Bio (SPHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,619 | -11,164 | -10,617 | -6,334 | -2,242 |
| Depreciation Amortization | 49 | 113 | 93 | 71 | 37 |
| Accounts receivable | 42 | -120 | -4 | 7 | 8 |
| Accounts payable and accrued liabilities | -100 | -446 | -651 | -707 | -514 |
| Other Working Capital | -1,168 | 250 | 348 | -277 | -416 |
| Other Operating Activity | 546 | 1,038 | 2,606 | 2,505 | 596 |
| Operating Cash Flow | $-3,250 | $-10,329 | $-8,225 | $-4,735 | $-2,531 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -3,008 | -16,471 | -453 | -250 | -250 |
| Sale Of Investment | 2,350 | 2,750 | 2,750 | 2,750 | 2,500 |
| Investing Cash Flow | $-658 | $-13,721 | $2,297 | $2,500 | $2,250 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 4,770 | N/A |
| Debt Repayment | N/A | -5,141 | -5,141 | -921 | -455 |
| Common Stock Issued | 2 | 36,112 | 36,243 | 843 | N/A |
| Financing Cash Flow | $2 | $30,971 | $31,102 | $4,692 | $-455 |
| Exchange Rate Effect | N/A | -2 | N/A | N/A | 1 |
| Beginning Cash Position | 12,800 | 5,881 | 5,881 | 5,881 | 5,881 |
| End Cash Position | 8,894 | 12,800 | 31,055 | 8,338 | 5,146 |
| Net Cash Flow | $-3,906 | $6,919 | $25,174 | $2,457 | $-735 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,250 | -10,329 | -8,225 | -4,735 | -2,531 |
| Free Cash Flow | -3,250 | -10,329 | -8,225 | -4,735 | -2,531 |